Inspire Medical Systems, Inc.
HealthcareNYSE:INSP · New York Stock Exchange
+$0.26 today
Vol 0.86M · Avg 1.12M
Income Statement
Follow revenue through to earnings
Review sales, margins, expenses, and profit trends to see what is actually driving reported earnings over time.
Earnings Waterfall
Revenue to Net Income
Key Ratios
Analysis
$915.2M of revenue converted into $131.1M of net income for the selected period. Gross margin is 85.7% and net margin is 12.0%, showing how much revenue survives after costs and taxes. EPS is $4.49, tying the income statement back to per-share earnings.
Income Statement
Annual data · 5 periods
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $912.0M +13.6% | $802.8M +28.5% | $624.8M +53.2% | $407.9M +74.7% | $233.4M | $809.6M | $921.6M | $731.2M |
| Cost of Revenue | $133.2M +8.3% | $123.0M +27.3% | $96.6M +46.1% | $66.1M +98.7% | $33.3M | $725.6M | $804.0M | $882.4M |
| Gross Profit | $778.8M +14.6% | $679.8M +28.7% | $528.2M +54.6% | $341.7M +70.8% | $200.1M | $8.9B | $7.6B | $6.2B |
| Gross Margin | 85.4% +0.7pp | 84.7% +0.1pp | 84.5% +0.8pp | 83.8% -2.0pp | 85.7% | 9.8% | 28.9% | 38.3% |
| Research & Development | $103.2M -9.6% | $114.1M -2.1% | $116.5M +69.8% | $68.6M +83.8% | $37.4M | $983.2M | $1.3B | $490.4M |
| Selling, General & Admin | $624.6M +17.9% | $529.6M +17.2% | $452.0M +40.9% | $320.7M +58.3% | $202.6M | $620.6M | $923.0M | -$1.5B |
| Operating Expenses | $727.8M +13.1% | $643.7M +13.2% | $568.5M +46.0% | $389.3M +62.2% | $240.0M | $5.3B | $7.0B | $8.7B |
| Depreciation & Amortization | $14.0M +113.1% | $6.5M +130.1% | $2.8M +53.2% | $1.9M +52.5% | $1.2M | $374.2M | $1.2B | $631.8M |
| EBITDA | $79.8M +22.7% | $65.0M +481.2% | -$17.1M +58.1% | -$40.7M -5.5% | -$38.6M | -$15.2B | $6.8B | $9.3B |
| EBITDA Margin | 8.7% +0.6pp | 8.1% +10.8pp | -2.7% +7.3pp | -10.0% +6.6pp | -16.5% | 5.6% | 46.3% | 42.0% |
| Operating Income | $51.0M +41.2% | $36.1M +189.6% | -$40.3M +15.4% | -$47.6M -19.4% | -$39.9M | $12.3B | $14.0B | -$15.7B |
| Operating Margin | 5.6% +1.1pp | 4.5% +10.9pp | -6.4% +5.2pp | -11.7% +5.4pp | -17.1% | 16.6% | 24.1% | 22.0% |
| Interest Income | $17.5M -24.6% | $23.2M +13.1% | $20.6M +307.1% | $5.0M +3940.0% | $125.0K | -$1.5B | -$1.6B | $405.0M |
| Interest Expense | $137.0K +522.7% | $22.0K | $0 -100.0% | $1.7M -21.2% | $2.1M | $1.1B | $1.0B | $1.2B |
| Other Income / Expenses | $14.7M -34.1% | $22.4M +9.8% | $20.4M +512.7% | $3.3M +256.8% | -$2.1M | -$1.5B | $1.4B | $1.2B |
| Income Before Tax | $65.7M +12.4% | $58.5M +393.6% | -$19.9M +55.0% | -$44.3M -5.5% | -$42.0M | $3.3B | $4.9B | $3.6B |
| Pre-Tax Margin | 7.2% -0.1pp | 7.3% +10.5pp | -3.2% +7.7pp | -10.9% +7.1pp | -18.0% | 20.8% | 18.7% | 26.2% |
| Income Tax Expense | -$79.7M -1712.6% | $4.9M +296.5% | $1.2M +103.4% | $613.0K +751.4% | $72.0K | $1.3B | -$1.6B | $745.2M |
| Net Income | $145.4M +171.8% | $53.5M +353.0% | -$21.2M +52.9% | -$44.9M -6.8% | -$42.0M | $4.9B | $4.8B | $4.7B |
| Net Margin | 15.9% +9.3pp | 6.7% +10.1pp | -3.4% +7.6pp | -11.0% +7.0pp | -18.0% | 12.4% | 17.5% | 22.5% |
| EPS (Basic) | $5 +175.0% | $2 +350.0% | -$1 +55.0% | -$2 -3.9% | -$2 | $400.8M | $703.2M | $1.3B |
| EPS (Diluted) | $5 +179.4% | $2 +343.1% | -$1 +55.0% | -$2 -3.9% | -$2 | $766.2M | $609.4M | $452.6M |
| Weighted Avg Shares | $29.4M -1.3% | $29.8M +1.6% | $29.3M +4.4% | $28.1M +3.0% | $27.3M | $757.8M | $925.8M | $1.1B |
| Weighted Avg Shares (Diluted) | $29.8M -2.6% | $30.5M +4.2% | $29.3M +4.4% | $28.1M +3.0% | $27.3M | $1.2B | $924.4M | $678.0M |
Older periods hidden.
Sign in to unlockCompetitors
Peer companies in the same sector
Brookdale Senior Living Inc.
NYSE:BKD
$3.21B
Integer Holdings Corporation
NYSE:ITGR
$3.09B
Arcus Biosciences, Inc.
NYSE:RCUS
$2.40B
Premier, Inc.
PINC
$2.34B
89bio, Inc.
ETNB
$2.20B
LeMaitre Vascular, Inc.
NASDAQ:LMAT
$2.10B
Addus HomeCare Corporation
NASDAQ:ADUS
$1.74B
PROCEPT BioRobotics Corporation
NASDAQ:PRCT
$1.46B
Ardent Health Partners, LLC
NYSE:ARDT
$1.34B
Artivion, Inc.
NYSE:AORT
$975.72M
SEC Filings
Recent regulatory filings
No filings found.
How much revenue does INSP generate?
Inspire Medical Systems, Inc. (INSP) reported $911.98M of revenue in fiscal 2025.
Is INSP profitable?
Inspire Medical Systems, Inc. (INSP) reported $145.42M of net income, with a net margin of 15.9%.
Explore More
Continue the stock analysis
Jump to another research area for this company.